Laurion Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$537K Buy
+448
New +$458K 0.01% 293
2024
Q4
Sell
-3,328
Closed -$2.76M 352
2024
Q3
$2.95M Buy
+3,328
New +$2.99M 0.04% 136
2022
Q3
Sell
-1,782
Closed -$578K 549
2022
Q2
$578K Sell
1,782
-38,742
-96% -$11.6M 0.01% 324
2022
Q1
$11.6M Buy
40,524
+38,377
+1,787% +$9.88M 0.14% 101
2021
Q4
$593K Sell
2,147
-121,435
-98% -$30.8M 0.01% 400
2021
Q3
$28.6M Buy
+123,582
New +$30.5M 0.12% 167
2020
Q4
Sell
-85,058
Closed -$12.6M 825
2020
Q3
$12.6M Buy
+85,058
New +$13.2M 0.15% 144
2019
Q3
Sell
-202,184
Closed -$22.5M 1159
2019
Q2
$22.4M Buy
+202,184
New +$23.8M 0.22% 110
2019
Q1
Sell
-10,694
Closed -$1.24M 1092
2018
Q4
$1.24M Buy
+10,694
New +$1.19M 0.02% 506
2018
Q1
Sell
-107,464
Closed -$8.65M 1515
2017
Q4
$9.08M Buy
+107,464
New +$9.14M 0.05% 369
2017
Q1
Sell
-44,900
Closed -$3.6M 1452
2016
Q4
$3.3M Buy
+44,900
New +$3.34M 0.03% 441
2016
Q2
Sell
-2,800
Closed -$202K 934
2016
Q1
$202K Buy
+2,800
New +$212K ﹤0.01% 687

Other funds holding LLY

Laurion Capital Management's LLY Position: Q2 2026 in Review

Laurion Capital Management opened a new position in Eli Lilly (LLY) in Q2 2026: 448 shares worth $537K. The stake represents 0.01% of the portfolio and ranks #293 among its holdings. This is a return to the name: Laurion Capital Management previously reported a position in LLY as recently as Q3 2024.

Laurion Capital Management first reported a position in LLY in Q1 2016 and has held it in 12 quarters since. The position peaked at $28.6M in Q3 2021. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Laurion Capital Management held 448 shares of Eli Lilly worth $537K as of Q2 2026.
  • Eli Lilly was a new Laurion Capital Management position in Q2 2026.
  • Eli Lilly made up 0.01% of Laurion Capital Management's portfolio in Q2 2026, its #293 holding.
  • Laurion Capital Management first reported a position in Eli Lilly in Q1 2016 and has held it in 12 quarters since.
  • Laurion Capital Management's Eli Lilly position peaked at $28.6M in Q3 2021.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Laurion Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.